Angioedema
|
phenotype |
Skin and Connective Tissue Diseases; Immune System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
18
|
8
|
0.100 |
None |
|
0 |
1
|
|
|
FACTOR XII (LOCARNO) PHENOTYPE
|
phenotype |
|
Finding
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Hereditary Angioedema Type III
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
4
|
3
|
0.100 |
None |
|
0 |
3
|
|
|
Urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
168
|
11
|
0.100 |
None |
|
0 |
1
|
|
|
Infiltrating duct carcinoma of female breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
21
|
10
|
0.300 |
None |
|
0 |
|
|
|
Increased bilirubin level (finding)
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
14
|
8
|
0.100 |
None |
|
0 |
1
|
|
|
Gastric Adenocarcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
453
|
235
|
0.300 |
None |
|
0 |
1
|
|
|
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.310 |
None |
0.500 |
2 |
|
2006 |
2014 |
Angioedemas, Hereditary
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
54
|
7
|
0.100 |
None |
1.000 |
8 |
2
|
2006 |
2015 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.040 |
None |
1.000 |
4 |
|
2016 |
2019 |
Activated Partial Thromboplastin Time measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
44
|
0.100 |
None |
1.000 |
4 |
7
|
2010 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Intelligence
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental Process
|
645
|
2093
|
0.100 |
None |
1.000 |
3 |
2
|
2018 |
2019 |
Parkinson Disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
2078
|
990
|
0.210 |
None |
1.000 |
2 |
|
2008 |
2010 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2018 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cardiac troponin I measurement
|
phenotype |
|
Laboratory Procedure
|
11
|
14
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Drug-induced tardive dyskinesia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
94
|
67
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
5
|
2012 |
2012 |
Glycine measurement
|
phenotype |
|
Laboratory Procedure
|
32
|
68
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Tardive Dyskinesia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
94
|
67
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Infectious Lung Disorder
|
group |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
185
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
6
|
2018 |
2018 |